Arbitration Clause in Attorney-Client Agreement Deemed Unenforceable Due to Lack of Informed Consent Bryan Dick-Ipsen v. Humphrey, Farrington & McClain, P.C., et al., 2024 IL App (1st) 241043 – Brief Summary – The… Read More → October 3, 2024
Asheville Arthritis and Osteoporosis Center Reports Data Breach After Unauthorized Access to IT Network On September 20, 2024, Asheville Arthritis and Osteoporosis Center, P.A. (“Asheville Arthritis”) filed a notice of data breach with the… Read More → October 3, 2024
A Rent-Seeking Laboratory and the Genesis of Many Mass Torts Over the past decade, mass tort litigation involving de minimis levels of impurities has skyrocketed. One need only turn on… Read More → October 3, 2024
Griffon Corporation Files Formal Notice of Data Breach On September 30, 2024, Griffon Corporation (“Griffon”) filed a notice of data breach with the Attorney General of Vermont after… Read More → October 3, 2024
Empereon Constar Announces Data Breach Following Incident at Partner Company On September 27, 2024, Constar Financial Services, better known as Empereon Constar, filed notice with the Attorney General of Maine… Read More → October 3, 2024
Cybersecurity Awareness Month: A timely reminder to review your security posture Explore four pressing cybersecurity challenges organizations face in 2024 and how to overcoming them… Read More → October 3, 2024
Sophos Firewall v21: Streamlined management How to make the most of the new features in Sophos Firewall v21.… Read More → October 3, 2024
Political Manipulation with Massive AI Model-driven Misinformation and Microtargeting Applying generative AI, bad actors could tailor disinformation campaigns to affect election outcomes on a massive scale with relatively little… Read More → October 3, 2024
And T-Mobile Makes Three: More Information Security Guidance for Telecommunications Carriers from the FCC Close on the heels of its Consent Decrees with TracFone and AT&T, on September 27, 2024, the Enforcement Bureau of… Read More → October 2, 2024
Unpacking Averages: Assessing FDA’s Postmarket Surveillance Under Section 522 Most months, I try to answer a well-focused question. This month, however, I want to simply take a broad look… Read More → October 2, 2024